Policy
The needs and consequences of the rapidly aging population continue to dominate health and social policies on the federal level. The Alliance for Aging Research plays a major role in informing and shaping the efforts of policymakers as the debate over these policies takes place. For the past 20 years, the Alliance for Aging Research has been committed to advancing scientific discoveries to improve the experience of aging. The Alliance will continue this mission while also serving as an objective “anti-silo” player in the area of healthy aging research – seeking to clear legislative and regulatory obstacles that impede progress.
- Access to Breakthroughs
- Drug Development
- Drug Safety
- Federal Funding
- Geriatric Training
- Regenerative Medicine
Related Publications
-
Press ReleaseAlliance for Aging Research Offers Online Resources for Healthy Aging and Longevity
The Alliance for Aging Research has launched a new and improved website, www.agingresearch.org, with a fresh new look, easier navigation, and new features that will help people stay informed about the latest information related to healthy aging and longevity. -
Press ReleaseAlliance for Aging Research Honors Senators Thad Cochran, Kent Conrad, FDA's Janet Woodcock for Advancing Healthy Aging
The Alliance for Aging Research, a non-profit organization that promotes scientific and medical research for healthier aging, honored Senator Thad Cochran (R-MS), Senator Kent Conrad (D-ND) and Dr. Janet Woodcock of the Food and Drug Administration with awards for advancing healthy aging through research. The Alliance presented the awards at its 14th Annual Bipartisan Congressional Awards Dinner on September 18, 2007, at the Willard Inter-Continental Hotel in Washington, DC. -
Press ReleaseAlliance Commends Senate Committee for Increase in FDA Funding
The Alliance for Aging Research today commends the Senate Agriculture, Rural Development, FDA and Related Agencies Appropriations Subcommittee for including a $186 million increase for the U.S. Food and Drug Administration (FDA) in its Fiscal Year 2008 appropriations bill. This increase over the Agency’s Fiscal Year 2007 funding level will begin to reverse the budget shortfalls it has experienced in recent years.
